<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02936778</url>
  </required_header>
  <id_info>
    <org_study_id>NL52508.078.15</org_study_id>
    <nct_id>NCT02936778</nct_id>
  </id_info>
  <brief_title>Status Asthmaticus on the Intensive Care Prospective - STATIC PRO</brief_title>
  <official_title>Risk Factors for Intensive Care Admission of Children With Severe Acute Wheeze or Asthma (SAA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maasstad Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Amphia Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tergooi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will prospectively assess the impact and relevance of several risk factors for
      children with severe acute asthma (SAA) or acute wheeze that have been identified in
      retrospective studies. Secondary we will assess short-term medical and psychosocial
      functioning in patient (and parents) admitted to a PICU for SAA/acute wheeze versus a control
      group admitted to a MC for SAA/acute wheeze.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Undertreatment in children admitted to a PICU with a diagnosis of SAA/acute wheeze</measure>
    <time_frame>Within the time of admission on the PICU/MC, preferably within 48 hours and during follow up after 3-6 months</time_frame>
    <description>Undertreatment is defined as: Patient is not using inhaled corticosteroids (ICS), or Patient is using ICS &lt; 7 days (counting from moment of admission to emergency department) according to treatment plan, or Patient is not using ICS according tot treatment plan.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exposure to triggers (single or combined)</measure>
    <time_frame>Within the time of admission on the PICU/MC, preferably within 24 hours</time_frame>
    <description>Pollution/airborne particulate matter (PM10), sensitization/allergen exposure, cigarette smoke exposure (measured by cotinine in urine), presence and type of virus in upper airway tract</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Socio-economic status</measure>
    <time_frame>Within the time of admission on the PICU/MC</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of previous asthma-related hospital admissions and/or PICU admissions.</measure>
    <time_frame>Within the time of admission on the PICU/MC and during follow up after 3-6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of disease, defined using the GINA criteria for stepwise management of asthma.</measure>
    <time_frame>Within the time of admission on the PICU/MC, preferably within 48 hours and during follow up after 3-6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of ADRB2-receptor polymorphisms compared to non-SAA population.</measure>
    <time_frame>Through study completion, preferably within the time of admission on the PICU/MC</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Childhood Asthma With Status Asthmaticus</condition>
  <arm_group>
    <arm_group_label>PICU (= case group)</arm_group_label>
    <description>Children aged 2-18 years admitted to a Paediatric Intensive Care Unit in the Netherlands, with a diagnosis of acute wheeze or SAA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MC (= control group)</arm_group_label>
    <description>Children aged 2-18 years admitted to a Medium Care in the Netherlands, with a diagnosis of acute wheeze or SAA.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 2-18 years admitted to a Medium Care or Paediatric Intensive Care Unit in the
        Netherlands, with a diagnosis of acute wheeze or SAA.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 2 and 18 years of age

          -  Admission to a PICU for SAA or acute wheeze or admission to a MC for SAA or acute
             wheeze

        Exclusion Criteria:

          -  Patient is outside of specified age range

          -  Down's Syndrome

          -  Congenital/acquired heart defect that interferes with normal SAA treatment

          -  Congenital/acquired airway defect (tracheomalacia/bronchomalacia)

          -  Primary/secondary immunodeficiency

          -  Pre-existing chronic pulmonary condition, known to mimic asthma: Cystic Fibrosis,
             Bronchopulmonary dysplasia, Bronchiolitis obliterans

          -  If both parents are not able to speak the Dutch language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shelley Boeschoten, Drs.</last_name>
    <phone>0031630035001</phone>
    <email>s.boeschoten@erasmusmc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3000WB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley A Boeschoten, Drs.</last_name>
      <phone>0031630035001</phone>
      <email>s.boeschoten@erasmusmc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2016</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Matthijs de Hoog</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Short-term medical and psychosocial functioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Status Asthmaticus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

